|

Avutometinib (VS-6766) + defactinib Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Oklahoma1

Indications

  • Mucinous Ovarian Cancer1
  • Endometrioid Cancer1
  • High-grade Serous Ovarian Cancer1
  • Solid Tumor1
  • Cervical Cancer1

Orlando, Florida1 trial

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

AdventHealth

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.